Health Professional Radio

Health Professional Radio HPR is an internet only radio network that has been broadcasting globally with dedicated audio strea This is all original content created by our own producers.

Health Professional Radio is a health dedicated media channel. The station format is "news and talk" with Health News, Health interviews, and audio shorts like "On This Day in Health", "Feature Hospital of the Day" and "Fun Facts and Health Statistics". Some content is clinical, some management orientated and some lifestyle orientated. All stories are archived on the web, cross posted and promoted on social media and there are transcripts posted on our website. The relevant state ministers have been advised and there is an ongoing awareness campaign though hospital boards and management. The Queensland minister has included a link to HPR on the Clinicians Knowledge Network on the department’s intranet. Health professionals listen to radio on computers and smart phones at nurses stations, clinics, in their cars and even during surgery – places they can’t use social media.

Cantex Pharmaceuticals - Continued Development of Cancer Therapies and MoreRead more: https://bit.ly/3U4Z6ow
19/01/2024

Cantex Pharmaceuticals - Continued Development of Cancer Therapies and More
Read more: https://bit.ly/3U4Z6ow

Join Dr. Steve Marcus, CEO of Cantex Pharmaceuticals, as he unveils groundbreaking studies on Azeliragon.

New type of AI-Powered Data Fills Gaps Left By Clinical TrialsRead more: https://bit.ly/3O6bOj6
19/01/2024

New type of AI-Powered Data Fills Gaps Left By Clinical Trials
Read more: https://bit.ly/3O6bOj6

Dive into the groundbreaking REAL-PE study results with Dr. Michael R. Jaff and Dr. Peter Monteleone. Explore the potential of real-world data in revolutionizing patient care for pulmonary embolism and beyond.

Immunocore - FDA Approved Treatment for Metastatic Uveal MelanomaRead more: https://bit.ly/3vNVNba
19/01/2024

Immunocore - FDA Approved Treatment for Metastatic Uveal Melanoma
Read more: https://bit.ly/3vNVNba

Explore the groundbreaking 3-year overall survival data from Immunocore's KIMMTRAK Phase 3 trial, presented by David Berman at ESMO 2023.

Spirovant Sciences - Potential of Gene Therapy in Targeting the Drivers of Cystic FibrosisRead more: https://bit.ly/47Pv...
19/01/2024

Spirovant Sciences - Potential of Gene Therapy in Targeting the Drivers of Cystic Fibrosis
Read more: https://bit.ly/47PvSNW

Learn how Spirovant Sciences is at the forefront of revolutionizing CF treatment by directly targeting and correcting the genetic roots of the disease.

Lucid Diagnostics - EsoGuard ® Esophageal DNA TestRead more: https://bit.ly/3U1tDnj
19/01/2024

Lucid Diagnostics - EsoGuard ® Esophageal DNA Test
Read more: https://bit.ly/3U1tDnj

Dr. Lishan Aklog, Chairman and CEO of Lucid Diagnostics, introduces groundbreaking tools for cancer prevention—the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device.

Ultra-Rare Inherited Form of High Cholesterol is Dangerously Underdiagnosed and UndertreatedRead more: https://bit.ly/3U...
19/01/2024

Ultra-Rare Inherited Form of High Cholesterol is Dangerously Underdiagnosed and Undertreated
Read more: https://bit.ly/3U9b3cS

Dr. Mary McGowan, Chief Medical Officer at the Family Heart Foundation, unveils findings from a critical study on the underdiagnosis and undertreatment of homozygous familial hypercholesterolemia (HoFH).

CIONIC - Bionic Clothing Medical Device for the Mobility ImpairedRead more: https://bit.ly/3RlhFln
14/12/2023

CIONIC - Bionic Clothing Medical Device for the Mobility Impaired
Read more: https://bit.ly/3RlhFln

Jeremiah Robison, Founder and CEO of CIONIC, shares the success story of the FDA-Cleared Cionic Neural Sleeve, the groundbreaking bionic clothing aiding individuals with neurological conditions.

Chronic Kidney Disease and the It Takes Two™ InitiativeRead more: https://bit.ly/41ubOin
14/12/2023

Chronic Kidney Disease and the It Takes Two™ Initiative
Read more: https://bit.ly/41ubOin

Dr. Charles Vega, Family Medicine Specialist, discusses the launch of 'It Takes 2,' a health initiative by Boehringer Ingelheim and Lilly.

Can Artificial Intelligence be used to Diagnose Glaucoma?Read more: https://bit.ly/48c6Ysa
14/12/2023

Can Artificial Intelligence be used to Diagnose Glaucoma?
Read more: https://bit.ly/48c6Ysa

Dr. Michael Boland, Site Director at Mass Eye and Ear, shares insights from the 2023 AAO annual meeting on AI and glaucoma.

Rheumatoid Arthritis and the Potential of Exploring Combination TherapiesRead more: https://bit.ly/3NtLjDT
14/12/2023

Rheumatoid Arthritis and the Potential of Exploring Combination Therapies
Read more: https://bit.ly/3NtLjDT

Dr. Terence Rooney, Janssen Research & Development, rheumatology, immunology, nipocalimab, IRIS study, anti-TNF combination, ACR Convergence 2023.

European Society for Medical Oncology (ESMO) 2023 - Abstracts   and  Read more: https://bit.ly/47YbE4W
07/12/2023

European Society for Medical Oncology (ESMO) 2023 - Abstracts and
Read more: https://bit.ly/47YbE4W

Dr. Arlene Siefker-Radtke, Professor at MD Anderson Cancer Center, presents findings from the Phase 3 THOR study on erdafitinib at ESMO 2023.

European Society for Medical Oncology (ESMO) 2023 - Presidential Symposium / Abstract  Read more: https://bit.ly/485sChU...
07/12/2023

European Society for Medical Oncology (ESMO) 2023 - Presidential Symposium / Abstract
Read more: https://bit.ly/485sChU

Dr. Nicolas Girard, Professor of Respiratory Medicine, presents primary results from the PAPILLON trial at ESMO 2023.

Address

PO Box 857
Fortitude Valley, QLD
4006

Telephone

+61731779900

Alerts

Be the first to know and let us send you an email when Health Professional Radio posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Health Professional Radio:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram